23 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
#SideEffects #Table ... #DecisionAid #Orals ... #DM2 #Diabetes ... #Endocrinology # ... Pharmacology #Management
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Oral Antihypertensive ... Dissection • CKD, DM ... Headache, Migraine, Opioid ... Comorbidities #pharmacology ... #table #management
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
patients taking opiouds ... D, use the following ... the equinalgesic oral ... #Pharmacology #Pain ... #Opiate #Opioid
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... cirrhosis) • Oral ... CKD or >2 of the following ... #Conversion #Table ... #medications #pharmacology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Most effective oral ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Combination #Tablets #Oral ... #DM2 #Pharmacology ... #Pills #Endocrinology
Levothyroxine tablet strengths are also color coded. Depending on the tablet shape (round vs oval) and
Levothyroxine tablet ... Depending on the tablet ... shape (round vs oval ... ThyroidDisorder #ColorCoded #Endocrinology ... #Pharmacology #
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
margin of safety in pharmacology ... the sublingual tablet ... use is resumed following ... Pharmacokinetics #Comparison #Table ... #Pharmacology #
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Januvia) - Once/day tablet ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table ... #endocrinology